NeurogesX (NGSX) Taps Advisor in Evaluating Development Objectives
Tweet Send to a Friend
NeurogesX, Inc. (Nasdaq: NGSX), has engaged JSB-Partners, a global life sciences advisor, to assist the Company in executing its business development objectives that include selecting potential development and commercial partners and entering into partnerships for the United States and other major global markets, which remain unpartnered, for its lead product candidate NGX-1998 and its commercialized product Qutenza® (capsaicin 8%) patch.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Santarus (SNTS) to Present Additional Data on UCERIS
- EnteroMedics (ETRM) Higher; Completes VBLOC Therapy Pre-PMA Meeting With FDA
- Maxwell Tech (MXWL) Recieves NASDAQ Notification Letter, Expects to Satisfy Conditions
Create E-mail Alert Related Categories
Corporate News, FDA
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
